Yogurt Associated with Lower Pre-Cancerous Bowel Growth in Men

Research published in the journal Gut shows that eating 2 or more weekly servings of yogurt may lower the risk of developing the abnormal growths, known as adenomas, that precede the development of bowel cancer.
 
Although previously published research suggests a correlation between yogurt consumption and a decreased risk of bowel cancer through a change in type and volume in gut microbiomes, limited research has been conducted that evaluates whether the correlation was associated with adenomas as well.
 
Therefore, investigators analyzed the diets and subsequent development of adenoma in approximately 32,606 men as a part of the Health Professionals Follow UP Study and 55,743 women who were part of the Nurses Health Study. All participants were known to have had a lower bowel endoscopy between 1986 and 2012. Every 4 years, they provided detailed information on lifestyle and diet, including their yogurt intake.
 
Investigators found that during the study period, 5811 adenomas developed in men and 8116 in the women. Compared with those who did not eat yogurt, men who ate 2 or more servings a week were 19% less likely to develop a conventional adenoma, according to the study. Patients who had adenomas that were highly likely to become cancerous or were located in the rectum had an even greater decreased risk of 26%.
 
The study authors noted that there was no association found for men with serrated adenoma, a more dangerous form, or for the participants who were women.
 
Further research is needed to confirm the science and understand the reasoning for the association, the authors concluded.
 
Reference
  1. Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer. BMJ Journals. Published June 18, 2019. https://gut.bmj.com/content/early/2019/05/22/gutjnl-2019-318374. Accessed June 21, 2019.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

A novel potential biomarker test could identify patients who would benefit from more advanced lung cancer screening.
In addition to a natural variation in genetic makeup, approximately 1 in 1000 people inherit a damaged or mutated copy of the BRCA1 gene from a parent.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$